Abcellera Biologics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Abcellera Biologics Inc
TickerABCL
CIK #0001703057
CUSIP00288U106
SectorLife Sciences - Pharmaceutical Preparations
Address2215 Yukon Street, Vancouver, BC V5Y 0A1
Source [EDGAR]
CIK Filing 2011 - 2025
[0001703057] 10-K
[0001703057] 10-Q
[0001703057] 3
[0001703057] 4
[0001703057] 5
[0001703057] 8-K
[0001703057] D
[0001703057] SC 13D
[0001703057] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Baker Bros Advisors LP Abcellera Biologics Inc [2024-02-14] 7.9
Baillie Gifford & Co Abcellera Biologics Inc [2023-01-18] 6.88
Capital World Investors Abcellera Biologics Inc [2022-02-11] 7.8
Hansen Carl L G Abcellera Biologics Inc [2021-02-16] 23.0
DCVC Bio LP Abcellera Biologics Inc [2021-02-09] 10.8
Thiel Peter Abcellera Biologics Inc [2020-12-28] 5.3
Viking Global Investors LP Abcellera Biologics Inc [2020-12-21] 7.2
Form 3/4/5 Filer 2011 - 2025
AbCellera Biologics Inc.
Hayden Michael R
Montalbano John S.
Lo Andrew
Thermopylae Holdings Ltd.
Stimart Tryn
Hansen Carl L. G.
Booth Andrew
Lecault Veronique
Falconer Ester
Hamer John
Ocko Matthew
JNK Capital Management, LLC
Bogue Zachary
Stead Kiersten
DCVC Bio GP, LLC
ZNM Capital Management, LLC
DCVC Bio, L.P.
Thiel Peter
Form 13F Holdings
Firm Period DFND Voting Shares
Baker Bros Advisors LP [2025-06-30] SOLE 27,525,640 27,525,640
Capital World Investors [2025-06-30] DFND 13,361,096 13,361,096
Baillie Gifford & Co [2025-06-30] DFND 7,519,311 8,715,008
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] OTR 0 4,996,419
Two Sigma Investments LP [2025-06-30] SOLE 4,110,852 4,110,852
ArrowMark Colorado Holdings LLC [2025-06-30] SOLE 4,105,095 4,105,095
Two Sigma Advisers LP [2025-06-30] SOLE 3,878,800 4,070,300
BlackRock, Inc. [2025-06-30] SOLE 3,447,157 3,680,794
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 3,475,200 3,475,200
UBS Group AG [2025-06-30] DFND 3,447,925 3,447,925
Millennium Management LLC [2025-06-30] SOLE 3,397,589 3,397,589
OrbiMed Advisors LLC [2025-06-30] SOLE 3,344,568 3,344,568
Renaissance Technologies LLC [2025-06-30] SOLE 3,307,429 3,307,429
Citadel Advisors LLC [2025-06-30] DFND 3,170,560 3,170,560
Tang Capital Management LLC [2025-06-30] OTR 0 2,600,000
Guardian Partners Inc [2025-06-30] SOLE 1,786,414 1,786,414
Baillie Gifford & Co [2025-06-30] SOLE 0 1,644,996
Susquehanna International Group LLP [2025-06-30] OTR 594,288 1,136,688
Morgan Stanley [2025-06-30] DFND 802,488 996,927
Novo Holdings A/S [2025-06-30] SOLE 652,529 652,529
Norges Bank [2025-06-30] SOLE 630,938 630,938
State Street Corp [2025-06-30] DFND 613,293 614,293
Intellectus Partners LLC [2025-06-30] SOLE 548,133 548,133
Driehaus Capital Management LLC [2025-06-30] SOLE 499,922 499,922
Royal Bank of Canada [2025-06-30] DFND 54,128 403,916
Geode Capital Management LLC [2025-06-30] DFND 363,188 363,188
Skandinaviska Enskilda Banken AB (publ) [2025-06-30] DFND 0 340,267
Pier 88 Investment Partners LLC [2025-06-30] SOLE 244,180 244,180
GSA Capital Partners LLP [2025-06-30] SOLE 238,539 238,539
Bank of America Corp /DE/ [2025-06-30] DFND 0 224,365
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com